Table 2.
Association between vitamin D from different sources and PD risk
| Odds Ratio | 95% CI | P-Value | |
|---|---|---|---|
| clinical cutoff analysis | |||
| Vit D deficiency ( total 25(OH)D <20 ng/mL) | 2.64 | (1.88,3.71) | <0.0001 |
| Vit D insufficiency (total 25(OH)D<30 ng/mL) | 2.13 | (1.58,2.89) | <0.0001 |
| quartile analysis | |||
| Total 25(OH) D | |||
| Q1 (4.3–21.8 ng/mL) | 2.66 | (1.76,4.03) | <0.0001 (trend test) |
| Q2 (21.8–29 ng/mL) | 1.89 | (1.23,2.91) | |
| Q3 (29–37 ng/mL) | 0.92 | (0.58,1.46) | |
| Q4 (>37 ng/mL) | Reference | ||
| 25(OH) D2 | |||
| Q1 (<1 ng/mL) | 2.04 | (1.24,3.37) | <0.0001 (trend test) |
| Q2 (1–3.25 ng/mL) | 1.84 | (1.02,3.33) | |
| Q3 (3.25–8 ng/mL) | 1.46 | (0.80,2.69) | |
| Q4 (>8ng/mL) | Reference | ||
| 25(OH) D3 | |||
| Q1 (6–19.3 ng/mL) | 2.39 | (1.60,3.58) | <0.0001 (trend test) |
| Q2 (19.3–26.0 ng/mL | 1.42 | (0.92,2.18) | |
| Q3 (26.0–34.1 ng/mL) | 1 | (0.65,1.56) | |
| Q4 (>34.1 ng/mL) | Reference | ||